🇺🇸 FDA
Patent

US 11033587

Administration of cells and cellular extracts for rejuvenation

granted A61KA61K31/7088A61K35/36

Quick answer

US patent 11033587 (Administration of cells and cellular extracts for rejuvenation) held by REGENICS AS expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENICS AS
Grant date
Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/7088, A61K35/36, A61K35/60, A61K38/02